Rifampin inhibits Toll‐like receptor 4 signaling by targeting myeloid differentiation protein 2 and attenuates neuropathic pain

Xiaohui Wang(Henan Academy of Sciences), Hang Yin(Cornell University), Keith A. Strand(Applied DNA Sciences (United States)), Michael N. Pham(University of Colorado Boulder), Christina Smith(University of Colorado Boulder), Peter M. Grace(The University of Texas MD Anderson Cancer Center), Jing Li(Ministry of Education of the People's Republic of China), Kui Cheng(Southern Medical University), Linda R. Watkins(University of Colorado Boulder)
The FASEB Journal
April 8, 2013
Cited by 77


Related Papers